Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention

Published:2010-05 Issue:18 Volume:55 Page:1923-1932
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Peterson Eric D.,Dai David,DeLong Elizabeth R.,Brennan J. Matthew,Singh Mandeep,Rao Sunil V.,Shaw Richard E.,Roe Matthew T.,Ho Kalon K.L.,Klein Lloyd W.,Krone Ronald J.,Weintraub William S.,Brindis Ralph G.,Rumsfeld John S.,Spertus John A.

Funder

Agency for Healthcare Research and Quality

Bristol-Myers Squibb

Merck Group

Sanofi-Aventis

St. Jude Medical, Inc.

American Heart Association

American College of Cardiology

Society of Thoracic Surgeons

Cordis Corporation

Eli Lilly & Company

Portola Pharmaceutical

Schering-Plough Corporation

AHA

Amgen

Johnson & Johnson

NIH

Atherotech and Roche Diagnostics

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference32 articles.

1. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

2. Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making;Arnold;Circ Cardiovasc Qual Outcomes,2008

3. Qualitative and mixed methods provide unique contributions to outcomes research;Curry;Circulation,2009

4. Integrating quality into the cycle of therapeutic development;Califf;J Am Coll Cardiol,2002

5. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score);Addala;Am J Cardiol,2004

Cited by 391 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?;Current Atherosclerosis Reports;2024-09-07

2. Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program;The American Journal of Cardiology;2024-07

3. Critical appraisal and assessment of bias among studies evaluating risk prediction models for in-hospital and 30-day mortality after percutaneous coronary intervention: a systematic review;BMJ Open;2024-06

4. Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis;European Heart Journal;2024-05-14

5. Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention;The American Journal of Cardiology;2024-05